 |
2JK9 |
THE STRUCTURE OF SPLA-RYANODINE RECEPTOR DOMAIN AND SOCS BOX CONTAINING 1 IN COMPLEX WITH A PAR-4 PEPTIDE |
B |
A |
|
|
 |
2QPY |
AR LBD with small molecule |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2QR9 |
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic Derivative Compound |
C |
A |
|
|
 |
2QSE |
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain complexed with Burned Meat Compound 4-OH-PhIP |
C |
A |
|
|
 |
2QXM |
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Compound PhIP |
C |
A |
|
|
 |
2QXV |
Structural basis of EZH2 recognition by EED |
B |
A |
|
|
 |
2QYF |
Crystal structure of the Mad2/p31(comet)/Mad2-binding peptide ternary complex |
F |
C |
|
|
 |
2QZO |
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916 |
C |
A |
|
|
 |
2R28 |
The complex Structure of Calmodulin Bound to a Calcineurin Peptide |
C |
AB |
EF Hand-like |
|
 |
2V51 |
STRUCTURE OF MAL-RPEL1 COMPLEXED TO ACTIN |
E |
A |
|
|
 |
2V52 |
STRUCTURE OF MAL-RPEL2 COMPLEXED TO G-ACTIN |
M |
A |
|
|
 |
2VNW |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)METHANAMINE |
I |
A |
|
|
 |
2VNY |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)AMINE |
I |
A |
|
|
 |
2VO0 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE |
I |
A |
|
|
 |
2VO3 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE |
I |
A |
|
|
 |
2VO6 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE |
I |
A |
|
|
 |
2VO7 |
STRUCTURE OF PKA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE |
I |
A |
Protein kinase-like (PK-like) |
|
 |
2VP7 |
DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX |
B |
A |
|
|
 |
2VPB |
DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX |
B |
A |
|
|
 |
2VPE |
DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX |
D |
C |
|
|
 |
2VPG |
DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX |
B |
A |
|
|
 |
2W73 |
HIGH-RESOLUTION STRUCTURE OF THE COMPLEX BETWEEN CALMODULIN AND A PEPTIDE FROM CALCINEURIN A |
K |
ABF |
|
|
 |
2Z32 |
Crystal structure of Keap1 complexed with Prothymosin alpha |
B |
A |
6-bladed beta-propeller |
|
 |
2Z34 |
Crystal structure of SpCia1/Asf1 complex with Hip1 |
C |
DA |
Immunoglobulin-like beta-sandwich |
|
 |
2Z5S |
Molecular basis for the inhibition of p53 by Mdmx |
R |
O |
|
|
 |
2Z5T |
Molecular basis for the inhibition of p53 by Mdmx |
P |
MO |
|
|
 |
2ZFX |
Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a synthetic peptide containing the NR2 box of DRIP 205 |
C |
A |
|
|
 |
2ZJD |
Crystal Structure of LC3-p62 complex |
D |
C |
beta-Grasp (ubiquitin-like) |
|
 |
2ZL9 |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZLA |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZLC |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZMH |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZMI |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZMJ |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZNE |
Crystal structure of Zn2+-bound form of des3-23ALG-2 complexed with Alix ABS peptide |
D |
B |
|
|
 |
2ZVV |
Crystal structure of Proliferating cellular nuclear antigen 1 and Short peptide from human P21 |
X |
YAB |
|
|
 |
2ZXN |
A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket |
C |
A |
|
|
 |
3BEJ |
Structure of human FXR in complex with MFA-1 and co-activator peptide |
E |
A |
Nuclear receptor ligand-binding domain |
|
 |
3BQD |
Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3BQO |
Crystal Structure of TRF1 TRFH domain and TIN2 peptide complex |
B |
A |
Telomeric repeat binding factor (TRF) dimerisation domain |
|
 |
3BRL |
Crystal Structure of LC8 S88E / Swa |
C |
A |
|
|
 |
3BU8 |
Crystal Structure of TRF2 TRFH domain and TIN2 peptide complex |
D |
B |
Telomeric repeat binding factor (TRF) dimerisation domain |
|
 |
3BUA |
Crystal Structure of TRF2 TRFH domain and APOLLO peptide complex |
F |
B |
Telomeric repeat binding factor (TRF) dimerisation domain |
|
 |
3C0T |
Structure of the Schizosaccharomyces pombe Mediator subcomplex Med8C/18 |
B |
A |
|
|
 |
3C2G |
Crystal complex of SYS-1/POP-1 at 2.5A resolution |
C |
A |
|
|
 |
3C5J |
Crystal structure of HLA DR52c |
C |
AB |
|
|
 |
3CFS |
Structural basis of the interaction of RbAp46/RbAp48 with histone H4 |
E |
B |
|
|
 |
3CQU |
Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
C |
A |
|
|
 |
3CQW |
Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
C |
A |
|
|
 |
3CS8 |
Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a |
B |
A |
Nuclear receptor ligand-binding domain |
|